Zymeworks
Zymeworks is a Canada-based biotechnology company that develops novel medicines for the treatment of cancer, autoimmune and inflammatory diseases.
Business Model:
Revenue: $31.6M
Employees: 51-500
Industries / Tags:
Detailed Zymeworks Information
Geographic Data
Address: 114 East 4th Avenue
City: Vancouver
State: british columbia
Zip: V5T 1G4
Country: CA
Financial Info
Stage:
post ipo equity
Raised Last:
$100M
Raised Total:$846M
Social
Metrics
3,120,334Website Global Rank
5,301Website Monthly Traffic
Twitter Followers
Description
Zymeworks is a Canada-based biotechnology company that develops novel medicines for the treatment of cancer, autoimmune and inflammatory diseases.
Contact Phone:
+16046781388
Contact Email:
Zymeworks went public on 5/3/2017 on the NYSE
Listed Exchange:
NYSE
IPO Date:
5/3/2017
IPO Valuation:
$324M
Ticker Symbol:
ZYME
IPO Price:
$13/share
Amount Raised:
$64M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2016 | Kairos Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
